Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）

NCT06691477 is registered in ClinicalTrials.gov with Beckman Coulter, Inc. as lead sponsor.

NCT NCT06691477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06691477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）
Lead sponsor
Beckman Coulter, Inc.
Phase
Observational
Overall status
Completed
Start date
April 10, 2023
Completion date
October 11, 2024
Enrollment
1,104 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, heart failure